Virpax Pharmaceuticals In...
(VRPX)
undefined
undefined%
At close: undefined
0.36
-11.86%
Pre-market Dec 16, 2024, 07:30 AM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Cash & Equivalents | 9.14M | 19.00M | 36.84M | 54.80K | 41.54K | 48.37K |
Short-Term Investments | - | - | - | - | - | - |
Long-Term Investments | - | - | - | - | - | - |
Other Long-Term Assets | - | - | - | 392.34K | - | - |
Receivables | - | - | - | - | 1.39K | - |
Inventory | - | - | - | - | 3.33K | - |
Other Current Assets | 702.98K | 678.37K | 2.73M | 18.27K | 3.79K | 13.13K |
Total Current Assets | 9.63M | 19.67M | 39.57M | 73.07K | 46.72K | 61.50K |
Property-Plant & Equipment | - | - | - | - | - | - |
Goodwill & Intangibles | - | - | - | - | - | - |
Total Long-Term Assets | - | - | - | 392.34K | - | - |
Total Assets | 9.63M | 19.67M | 39.57M | 465.41K | 46.72K | 61.50K |
Account Payables | - | 37.64K | 19.84K | 22.11K | 3.50K | 6.55K |
Deferred Revenue | - | - | - | -1.05M | -3.5 | -6.55K |
Short-Term Debt | - | - | - | 543.99K | 1.26M | 500.00K |
Other Current Liabilities | 7.69M | 3.06M | 2.06M | 3.08M | 1.50M | 740.21K |
Total Current Liabilities | 7.69M | 3.09M | 2.09M | 3.66M | 2.78M | 1.25M |
Long-Term Debt | - | - | - | 1.02M | - | - |
Other Long-Term Liabilities | - | - | - | - | - | - |
Total Long-Term Liabilities | - | 1.09K | - | 1.02M | - | 500.00K |
Total Liabilities | 7.69M | 3.09M | 2.09M | 4.68M | 2.78M | 1.25M |
Total Debt | - | - | - | 1.57M | 1.26M | 500.00K |
Common Stock | 12.00 | 117.00 | 117.00 | 31.00 | 30.00 | 29.00 |
Retained Earnings | -59.54M | -44.35M | -22.70M | -10.65M | -6.31M | -3.00M |
Comprehensive Income | - | -0.00 | -0.00 | - | -0.00 | - |
Shareholders Equity | 1.93M | 16.58M | 37.48M | -4.22M | -2.73M | -1.19M |
Total Investments | - | - | - | - | - | - |